|
11th ANNUAL DRUG DISCOVERy Leaders Summit
The Pharmaceutical industry is experiencing declining productivity and success rates. To stay competitive companies are both increasing collaborations and re-evaluating their drug discovery strategies in order to reduce attrition rates at later stages. Various research and decision making tools such as enabling technologies, biomarkers, and drug design are being enabled at different stages of the discovery process in order to revitalise efficiency and yield. Linking data produced during development stages back into discovery to produce translational and personlised medicine is also being utilised to bridge the gap between discovery and development.
The 11th Annual Drug Discovery Leaders Summit 2010 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 175 attendees to gain knowledge and insights into the entire Drug Discovery marketplace.
The event explores core topics such as R&D strategies, biologics, medicinal chemistry, assay development and screening techniques, bioinformatics, biomarkers, diagnostics and translational & personalised medicine.
Do not miss out on the opportunity to learn how you can lower your attrition rate though developing more productive R&D strategies, effective use of discovery technologies, and making use of later stage knowledge by linking data back into discovery through translational and personalised medicine technique
|
About the Event
